<DOC>
	<DOCNO>NCT01246791</DOCNO>
	<brief_summary>The purpose study assess pharmacokinetic profile norethisterone ethinyl estradiol single oral administration NPC-01 healthy female volunteer . Pharmacokinetics norethisterone ethinyl estradiol evaluate basis AUC , Cmax , tmax , t1/2 , MRT , kel AUCâˆž .</brief_summary>
	<brief_title>Pharmacokinetics NPC-01 After Single Oral Administration Healthy Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Mestranol</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone acetate , ethinyl estradiol , ferrous fumarate drug combination</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Norinyl</mesh_term>
	<criteria>Healthy female age 20 35 year BMI:18.026.0 Females pregnant Drug use affect sex hormone secretion</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>NPC-01</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy female volunteer</keyword>
	<keyword>Norethisterone</keyword>
	<keyword>Ethinyl Estradiol</keyword>
</DOC>